Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin use and clinical outcomes in patients with COVID-19: An updated systematic review and meta-analysis
Rimesh Pal, Mainak Banerjee, Urmila Yadav, et al.
Postgraduate Medical Journal (2021) Vol. 98, Iss. 1159, pp. 354-359
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147 824 patients
Carlos Díaz-Arocutipa, Beatriz Melgar-Talavera, A Alvarado-Yarasca, et al.
International Journal of Infectious Diseases (2021) Vol. 110, pp. 374-381
Open Access | Times Cited: 63
Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis
Αναστάσιος Κόλλιας, Konstantinos G. Kyriakoulis, Ioannis Kyriakoulis, et al.
Atherosclerosis (2021) Vol. 330, pp. 114-121
Open Access | Times Cited: 57
Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond
Nabil G. Seidah, Damien Garçon
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 10, pp. 821-830
Open Access | Times Cited: 55
The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis
Kuan‐Sheng Wu, Pei‐Chin Lin, Yao-Shen Chen, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 874-884
Open Access | Times Cited: 44
Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial)
Nirmal Ghati, Sushma Bhatnagar, Manjit Mahendran, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 35
Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study
Ailiana Santosa, Stefan Franzén, Jonatan Nåtman, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study
Srikanth Umakanthan, Sanjum Senthil, Stanley John, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30
Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review
Carles Vilaplana-Carnerero, Maria Giner‐Soriano, Ángela Domı́nguez, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1206-1206
Open Access | Times Cited: 18
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
Stanisław Surma, Maciej Banach, Joanna Lewek
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 39
A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
Imtiaz A. Samjoo, Alexandra Hall, Connie Chen, et al.
Journal of Comparative Effectiveness Research (2024) Vol. 13, Iss. 10
Open Access | Times Cited: 6
Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets
Maria Proto, Donatella Fiore, Chiara Piscopo, et al.
Progress in Lipid Research (2021) Vol. 82, pp. 101099-101099
Open Access | Times Cited: 29
Acute myocardial injury in patients with COVID-19: Possible mechanisms and clinical implications
I Rusu, Malina Turlacu, Miruna Mihaela Micheu
World Journal of Clinical Cases (2022) Vol. 10, Iss. 3, pp. 762-776
Open Access | Times Cited: 20
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19
Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases
Naser‐Aldin Lashgari, Nazanin Momeni Roudsari, Seyed Saeed Tamehri Zadeh, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 57-75
Open Access | Times Cited: 18
Positionspapier zum Post-COVID-Syndrom
Elisabeth Schieffer, Denise Hilfiker‐Kleiner, Axel Schlitt, et al.
Deleted Journal (2025)
Closed Access
Atorvastatin Attenuated the Inflammatory Outcomes of COVID-19: A Double-Blind, Randomized Controlled Trial
Hajar Shokri‐Afra, Sudabe Baghery moghadam, Ziaeddin Oladi, et al.
Journal of Reports in Pharmaceutical Sciences (2025) Vol. 13, Iss. 1
Open Access
Do Statins Affect Viral Infections Encountered by International Travelers?
Chinmay Jani, Christian Mouchati, Nour Abdallah, et al.
Tropical Medicine and Infectious Disease (2025) Vol. 10, Iss. 3, pp. 73-73
Open Access
The role of lovastatin in the attenuation of COVID-19
Sajad Karampoor, Khashayar Hesamizadeh, Zinat Shams, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108192-108192
Open Access | Times Cited: 23
Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
Berta Soldevila, Manel Puig‐Domingo, Mónica Marazuela
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 23, Iss. 2, pp. 137-150
Open Access | Times Cited: 22
The impact of statin therapy on in‐hospital prognosis and endothelial function of patients at high‐to‐very high cardiovascular risk admitted for COVID‐19
Vanessa Bianconi, Massimo R. Mannarino, Elena Cosentini, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 9
The impact of race on survival in metastatic prostate cancer: a systematic literature review
Stephen J. Freedland, Imtiaz A. Samjoo, Emily Rosta, et al.
Prostate Cancer and Prostatic Diseases (2023) Vol. 26, Iss. 3, pp. 461-474
Open Access | Times Cited: 8
Efficacy of Statin Therapy in Patients with Hospital Admission for COVID-19
Daein Choi, Qinzhong Chen, Sascha N. Goonewardena, et al.
Cardiovascular Drugs and Therapy (2021) Vol. 36, Iss. 6, pp. 1165-1173
Open Access | Times Cited: 17
Coronaviruses, cholesterol and statins: Involvement and application for Covid-19
Stéphane Orlowski, Jean‐Jacques Mourad, Antonio Gallo, et al.
Biochimie (2021) Vol. 189, pp. 51-64
Open Access | Times Cited: 15
Statin Use in Relation to COVID-19 and Other Respiratory Infections: Muscle and Other Considerations
Beatrice A. Golomb, Junhee Han, Peter H. Langsjoen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4659-4659
Open Access | Times Cited: 6
Dyslipidaemia and mortality in COVID-19 patients: a meta-analysis
Marco Zuin, Gianluca Rigatelli, Claudio Bilato, et al.
QJM (2020) Vol. 114, Iss. 6, pp. 390-397
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top